For Physicians
California Pacific Medical Center's Liver Disease Management and Transplant team is available to assist with your complex case patients. Read about our referral process for further details. We have 12 outreach clinics in Northern California and Nevada that we visit to evaluate and monitor patients with liver disease. We also lecture locally and internationally and have online information and tools to provide further information about liver disease and transplantation.
Visiting GI Scholar Program at California Pacific Medical Center: Northern California and Nevada gastroenterologists are welcome to participate in our monthly program that offers an "insider" view of our liver disease and complex gastroenterology programs.
Expert Insight Into Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C is the first course in the HBV Advanced Certificate Program V, a free CME/CE program from Projects In Knowledge. A total of 0.75 AMA PRA Category 1 Credits™ is offered.
Hep B Free Campaign Materials
- Practical Architecture of HBV Screening Events
- English Hep B Results Letter: Ag Negative, Ab Negative
- Chinese Hep B Results Letter: Ag Negative, Ab Negative
- Korean Hep B Results Letter: Ag Negative, Ab Negative
- Vietnamese Hep B Results Letter: Ag Negative, Ab Negative
- English Hep B Results Letter: Ag Negative, Ab Positive
- Chinese Hep B Results Letter: Ag Negative, Ab Positive
- Korean Hep B Results Letter: Ag Negative, Ab Positive
- Vietnamese Hep B Results Letter: Ag Negative, Ab Positive
- English Hep B Results Letter: Ag Positive
- Chinese Hep B Results Letter: Ag Positive
- Korean Hep B Results Letter: Ag Positive
- Hepatitis B Radio PSA (mp3 file)
- Hepatitis B Radio PSA Transcript
Recent Articles Authored by our Physicians Include:
- Frenette C, Gish R, Review of Selected Liver Cancer Abstracts from the AASLD Meeting in SF 2008 for NATAP. AASLD Nov. 2008.
- Block TM, Marrero J, Gish RG, Sherman M, London WT, Srivastava S, Wagner PD. The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop. Cancer Biomark. 2008;4(1):19-33. Review.
- Xu L, Guo L, Shen Z, Loss G, Gish R, Wasilenko S, Mason AL. Duplication of MER115 on chromosome 4 in patients with primary biliary cirrhosis. Liver Int. 2008 Oct 10.
- Veenstra DL, Spackman DE, Di Bisceglie A, Kowdley KV, Gish RG. Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effective analysis. Aliment Pharmacol Ther. 2008 Jun;27(12):1240-52. Epub 2008 Mar 27. Review.
- Gish RG, Baron A. Hepatocellular carcinoma (HCC): current and evolving therapies. IDrugs. 2008 Mar;11(3):198-203. Review.
- Gish R, Marrero JB, Tong MJ. Medical therapies to extend survival in hepatocellular carcinoma. Clin Adv Hematol Oncol. 2008 Aug;6(8):1-14; quiz 15.
- Gish RG, Lok AS, Chang TT, de Man RA, Gadano A, Sollano J, Han KH, Chao YC, Lee SD, Harris M, Yang J, Colonno R, Brett-Smith H. Entecavir Therapy for Patients with HBeAg-Positive Chronic Hepatitis B. Gastroenterology. 2007 Nov;133(5):1437-44.
- Sulkowski MS, Wasserman R, Brooks L, Ball L, Gish R. Changes in haemoglobin
during interferon alpha-2b plus ribavirin combination therapy for chronic
hepatitis C virus infection. J Viral Hepat. 2004 May;11(3):243-50.
California Pacific is at the forefront of advances and research. The liver team conducts multiple using new, ground-breaking medications in the areas of viral hepatitis, liver cancer and liver transplantation, and recruits patients from Northern California and Nevada.
Liver Disease and Transplant Info. & Tools
Access our handouts on more than 30 liver disease topics including hepatitis C and fatty liver. Our clinical pathways and disease guidelines include:
- Hepatitis C Clinical Pathway (pdf file)
- Liver Biopsy Clinical Pathway
- Liver Biopsy Management Guideline Protocol (pdf file)
Review topics our hepatologists have presented or request more information about our speaker's bureau.